BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 198083)

  • 1. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary hCG excretion patterns of patients with chorionic tumor during chemotherapy: indication of remission by chemotherapy].
    Isojima S; Koyama K; Kamata T; Naka O; Kushiki N
    Nihon Naibunpi Gakkai Zasshi; 1973 Dec; 49(12):1424-35. PubMed ID: 4359526
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
    Jones WB; Lewis JL; Lehr M
    Am J Obstet Gynecol; 1975 Mar; 121(5):669-73. PubMed ID: 46716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine.
    Ayala AR; Nisula BC; Chen HC; Hodgen GD; Ross GT
    J Clin Endocrinol Metab; 1978 Oct; 47(4):767-73. PubMed ID: 95624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease.
    Nishimura R; Endo Y; Tanabe K; Ashitaka Y; Tojo S
    J Endocrinol Invest; 1981; 4(3):349-58. PubMed ID: 7320438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant trophoblastic neoplasia. Monitoring of therapy.
    Kolstad P; Hoeg K; Norman N
    Acta Obstet Gynecol Scand; 1972; 51(3):275-81. PubMed ID: 4342019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluctuations in the level of chorionic gonadotropin in the process of primary treatment of trophoblastic tumors].
    SemenovskiÄ­ AV
    Akush Ginekol (Mosk); 1978 Dec; (12):21-4. PubMed ID: 216278
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
    Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
    Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).
    Bagshawe KD; Wilson H; Dublon P; Smith A; Baldwin M; Kardana A
    J Obstet Gynaecol Br Commonw; 1973 May; 80(5):461-8. PubMed ID: 4351453
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience of human chorionic gonadotropin assays in gestational trophoblastic tumors.
    Huang SC; Hsieh CY; Chen RJ; Hsieh FJ; Chen HC; Ouyang PC
    J Formos Med Assoc; 1991 Apr; 90(4):335-41. PubMed ID: 1680961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
    Goldstein DP; Nudemberg F; Lymeburner N; Levesque L; Shore C
    J Surg Oncol; 1973; 5(1):1-8. PubMed ID: 4736212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY; Cole LA; Kardana A
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of urinary steroid analysis in chorionic neoplasia.
    Kodama M; Totani R; Kodama T
    Am J Obstet Gynecol; 1977 Mar; 127(6):628-37. PubMed ID: 190888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N; Okamoto M; Tomoda Y
    Obstet Gynecol; 1973 Jul; 42(1):1-11. PubMed ID: 4352641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the heterogeneity of urinary HCG molecules by RRA and RIA (author's transl)].
    Kushiki N; Fuzishima K; Kinoshita T; Ino H; Naka O
    Nihon Naibunpi Gakkai Zasshi; 1979 Sep; 55(9):1076-88. PubMed ID: 227758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.